Home» Circulars» Viewcirculars Back
 
EU Public Procurement Act and Potential Implications for India Pharmaceutical Manufacturers
 

 

PxlNwLtrHeaderLogo

PXL/HO/Cir-099/2026-27                                                                        Date: 18.11.2026

Hyderabad

 

Dear Sir/Madam,

 

Subject: EU Public Procurement Act and Potential Implications for India Pharmaceutical Manufacturers

 

The European Commission has proposed a new regulation titled "Public Procurement Act" (COM(2026) 590 final), which seeks to revise the existing EU public procurement framework and introduce measures relating to European preference, supply-chain resilience and strategic autonomy in public procurement.

 

The proposed regulation may have implications for Indian pharmaceutical manufacturers and exporters supplying medicines, Active Pharmaceutical Ingredients (APIs) and other pharmaceutical products to the European Union, particularly regarding government and public-sector procurement contracts.

 

In this regard, PHARMEXCIL is undertaking an assessment of the potential implications of the proposed regulation on Indian pharmaceutical exports to the EU and would appreciate receiving inputs from member companies.

 

We request companies exporting pharmaceutical products to the EU, particularly those participating in public procurement or institutional tenders, to kindly share their feedback using the below Link:

 

Companies are also requested to share any relevant data, specific examples or supporting information that may help assess the potential impact of the proposed regulation.

 

Your inputs will assist PHARMEXCIL in consolidating industry feedback and taking up the matter with the Department of Commerce, Government of India, for examination and appropriate intervention, wherever necessary.

 

We request you to kindly share your feedback and inputs at the earliest.

 

Link to fill up: https://forms.gle/v5zFNi77somgUNxKA

 

Thank you for your cooperation.

 

With Regards

 

With Regards,

 

 

Raja Bhanu K

Director General